Organ Transplant Focused TransMedics to Raise Up To $91 Million in IPO

On 4/22/19, TransMedics updated their filing for an IPO to raise up to $91 million. The commercial stage company has developed an organ transplant support system for heart, lung and liver transplans that improve patient outcomes. The company intends to trade under the symbol, “TMDX.”